Telmisartan Effects on Insulin Sensitivity and Adipose Tissue Function

Telmisartan, an angiotensin II type 1 receptor blocker with partial PPARγ agonism, has emerged as a multifunctional agent improving insulin sensitivity and modulating adipose tissue physiology. By attenuating renin–angiotensin signalling, telmisartan reduces oxidative stress and inflammation in adipocytes, promotes beneficial redistribution of lipid stores and enhances glucose uptake in peripheral tissues. Mechanistic studies reveal activation of the AMPK/SIRT1 axis in skeletal muscle and direct effects on adipose depots, including reduction of adipocyte hypertrophy, suppression of pro-inflammatory cytokines and stimulation of browning. These effects collectively improve metabolic homeostasis, lower circulating free fatty acids and counteract obesity-related hypertension. Clinically, telmisartan has been associated with improved glycaemic control, reduced adipose tissue macrophage infiltration and augmented microvascular perfusion. Its pleiotropic actions make it a promising therapeutic for metabolic syndrome and type 2 diabetes.

Research from Nature Portfolio

Recent studies have demonstrated that telmisartan can induce browning of mature white adipocytes through modulation of macrophage phenotype. Treatment promotes a shift towards anti-inflammatory M2 macrophage polarisation, increasing catecholamine release that in turn stimulates thermogenic gene expression, mitochondrial biogenesis and oxygen consumption in adipocytes. In rodent models, short-term telmisartan administration elevates markers of both browning and M2 activation within white adipose depots; macrophage depletion attenuates these effects, indicating a paracrine immunometabolic mechanism. This research highlights a novel pathway by which an angiotensin receptor blocker may enhance energy expenditure and ameliorate adipose dysfunction.

Telmisartan Effects on Insulin Sensitivity and Adipose Tissue Function publication trend

The graph below shows the total number of articles in telmisartan effects on insulin sensitivity and adipose tissue function across all publications each year (not limited to Nature Index journals).

Technical terms

PPARγ: A nuclear receptor that regulates adipocyte differentiation, lipid storage and insulin sensitivity.

AMPK (adenosine monophosphate-activated protein kinase): A cellular energy sensor that promotes glucose uptake and fatty acid oxidation under low energy conditions.

Browning of adipose tissue: The conversion of white adipocytes into beige-like cells with increased mitochondrial content and thermogenic capacity.

M2 macrophage polarisation: An anti-inflammatory activation state of macrophages that supports tissue repair and secretes factors promoting thermogenesis.

Adiponectin: An adipocyte-derived hormone that enhances insulin sensitivity and exhibits anti-inflammatory properties.

References

1. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovascular Diabetology (2012).
2. Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization. Scientific Reports (2019).
3. Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension. Cardiovascular Diabetology (2021).
4. Effectiveness of Telmisartan as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats. Open Journal of Endocrine and Metabolic Diseases (2013).